Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11702418 SOS1 inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Mirati Therapeutics

0

Current Assignee

Mirati Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 18, 2023

0

Patent Application Number

171275820

Date Filed

December 18, 2020

0

Patent Citations

US Patent 8163763 Pyrimidine compounds, compositions and methods of use

0

US Patent 8426401 Azetidinyl diamides as monoacylglycerol lipase inhibitors

0

US Patent 9562019 Substituted pyridazines as EGFR and/or KRAS inhibitors

0

US Patent 9840516 Substituted quinazolines as inhibitors of KRAS G12C

0

US Patent 10125134 KRas G12C inhibitors

0

Patent Primary Examiner

Rebecca L Anderson

0

CPC Code

0

0

0

0

0

0

0

0

...

The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11702418 SOS1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool